The Patent Trial and Appeal Board (PTAB) has recently agreed to review two electrocardiogram technology patents held by Apple Inc. These patents are the subjects of a current litigation filed by Apple against a medical software firm, AliveCor Inc., in a California federal court.
AliveCor, known for its innovative heart monitor KardiaMobile, first filed a complaint regarding Apple’s electrocardiogram technology in 2020. This led to a series of legal confrontations affecting both companies.
In early November 2023, Apple respectively rejected AliveCor’s claims that Apple Watch’s heart rate monitoring feature was infringing on their patents.
The recent decision by the PTAB to examine Apple’s patents could potentially impact the ongoing trial and affect the pattern of future lawsuits in the technology and health sectors.
For detailed information about the lawsuit, refer to the original article at Law360.